1. Home
  2. PHAR vs YRD Comparison

PHAR vs YRD Comparison

Compare PHAR & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • YRD
  • Stock Information
  • Founded
  • PHAR 1988
  • YRD 2012
  • Country
  • PHAR Netherlands
  • YRD China
  • Employees
  • PHAR N/A
  • YRD N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • YRD Finance: Consumer Services
  • Sector
  • PHAR Health Care
  • YRD Finance
  • Exchange
  • PHAR Nasdaq
  • YRD Nasdaq
  • Market Cap
  • PHAR 587.5M
  • YRD 554.6M
  • IPO Year
  • PHAR N/A
  • YRD 2015
  • Fundamental
  • Price
  • PHAR $10.03
  • YRD $6.28
  • Analyst Decision
  • PHAR Strong Buy
  • YRD
  • Analyst Count
  • PHAR 3
  • YRD 0
  • Target Price
  • PHAR $30.00
  • YRD N/A
  • AVG Volume (30 Days)
  • PHAR 3.0K
  • YRD 91.8K
  • Earning Date
  • PHAR 05-08-2025
  • YRD 06-20-2025
  • Dividend Yield
  • PHAR N/A
  • YRD 6.23%
  • EPS Growth
  • PHAR N/A
  • YRD N/A
  • EPS
  • PHAR N/A
  • YRD 2.48
  • Revenue
  • PHAR $320,708,000.00
  • YRD $795,426,969.00
  • Revenue This Year
  • PHAR $12.39
  • YRD N/A
  • Revenue Next Year
  • PHAR $9.84
  • YRD N/A
  • P/E Ratio
  • PHAR N/A
  • YRD $2.50
  • Revenue Growth
  • PHAR 24.13
  • YRD 18.59
  • 52 Week Low
  • PHAR $6.65
  • YRD $4.12
  • 52 Week High
  • PHAR $11.07
  • YRD $9.20
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 71.76
  • YRD 48.71
  • Support Level
  • PHAR $8.60
  • YRD $6.13
  • Resistance Level
  • PHAR $10.28
  • YRD $6.50
  • Average True Range (ATR)
  • PHAR 0.30
  • YRD 0.27
  • MACD
  • PHAR 0.17
  • YRD 0.02
  • Stochastic Oscillator
  • PHAR 88.79
  • YRD 61.74

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an advanced, AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

Share on Social Networks: